MEDI-FIRST

Product NDC: 71927-017
11-digit product format: 719270017
Labeler code: 71927
Product ID: 71927-017_5aaf2a9e-48de-0c33-e063-6294a90ad933
Type: HUMAN OTC DRUG
Nonproprietary name: Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate
Dosage form: OINTMENT
Route: TOPICAL
Labeler: Orazen Inc
Application: M004
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2025-09-03
Substance: BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Active strength: 400; .0035; 5000 [USP'U]/g; g/g; [USP'U]/g
Pharmacologic classes: Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	71927-017-04	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	71927-017-03	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	71927-017-02	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71927-017-04	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71927-017-03	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71927-017-02	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71927-017-04	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71927-017-03	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71927-017-02	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71927-017-04	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71927-017-03	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71927-017-02	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71927-017-04	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71927-017-03	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71927-017-02	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71927-017-04	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71927-017-03	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71927-017-02	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71927-017-04	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71927-017-03	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71927-017-02	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71927-017-04	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71927-017-03	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71927-017-02	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: MEDI-FIRST
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
BACITRACIN ZINC	400 [USP'U]/g
NEOMYCIN SULFATE	.0035 g/g
POLYMYXIN B SULFATE	5000 [USP'U]/g

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
89Y4M234ES	Internal UNII lookup
057Y626693	Internal UNII lookup
19371312D4	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
204602	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
f4e4d0a4-b90c-99b0-e053-2995a90ab423	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
99e684e6-f435-feb8-d2bb-3a546f1cb768	Product name	2	20161117
25340b3b-3e4c-4ff8-abf6-3e62ec46bd0c	Product name	1	20160603
2d352c73-a357-4193-a4de-dfdf9a2ac8e4	Product name	1	20150819
b045ad64-0f28-9a02-2f9b-b34d94fb2278	Product name	1	20140508
b6082387-f592-1148-0844-bd068fd213fb	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Indexing SPL table
NDC	Effective	Indexing SPL	Related label
71927-017-02	2025-09-03	2cef2736-9e69-d83d-e063-dadaa90ab31f	71927-017-01, -02, MEDI-FIRST Triple Antibiotic Ointment
71927-017-02	2025-09-03	2cef2736-9e69-d83d-e063-dadaa90ab31f	71927-017-01, -02, MEDI-FIRST Triple Antibiotic Ointment
71927-017-03	2025-09-03	2cef2736-622e-d83d-e063-dadaa90ab31f	71927-017-01, -03, MEDI-FIRST Triple Antibiotic Ointment
71927-017-03	2025-09-03	2cef2736-622e-d83d-e063-dadaa90ab31f	71927-017-01, -03, MEDI-FIRST Triple Antibiotic Ointment
71927-017-04	2025-09-03	2cef2736-7150-d83d-e063-dadaa90ab31f	71729-017-01, -04 MEDI-FIRST PLUS Triple Antibiotic Ointment
71927-017-04	2025-09-03	2cef2736-7150-d83d-e063-dadaa90ab31f	71729-017-01, -04 MEDI-FIRST PLUS Triple Antibiotic Ointment
71927-017-02	2025-01-30	2cef2736-9e69-d83d-e063-dadaa90ab31f	71927-017-01, -02, MEDI-FIRST Triple Antibiotic Ointment
71927-017-02	2025-01-30	2cef2736-9e69-d83d-e063-dadaa90ab31f	71927-017-01, -02, MEDI-FIRST Triple Antibiotic Ointment
71927-017-03	2025-01-30	2cef2736-622e-d83d-e063-dadaa90ab31f	71927-017-01, -03, MEDI-FIRST Triple Antibiotic Ointment
71927-017-03	2025-01-30	2cef2736-622e-d83d-e063-dadaa90ab31f	71927-017-01, -03, MEDI-FIRST Triple Antibiotic Ointment
71927-017-04	2025-01-30	2cef2736-7150-d83d-e063-dadaa90ab31f	71729-017-01, -04 MEDI-FIRST PLUS Triple Antibiotic Ointment
71927-017-04	2025-01-30	2cef2736-7150-d83d-e063-dadaa90ab31f	71729-017-01, -04 MEDI-FIRST PLUS Triple Antibiotic Ointment

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
71927-017-01	MEDI-FIRST	0.5 g in 1 POUCH	OINTMENT	0.5	2
71927-017-01	MEDI-FIRST	0.5 g in 1 POUCH	OINTMENT	0.5	2
71927-017-01	MEDI-FIRST	0.5 g in 1 POUCH	OINTMENT	0.5	2
71927-017-02	MEDI-FIRST	25 in 1 BOX	OINTMENT	25	2
71927-017-03	MEDI-FIRST	144 in 1 BOX	OINTMENT	144	2
71927-017-04	MEDI-FIRST	25 in 1 BOX	OINTMENT	25	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71927-017	MEDI-FIRST (BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE) OINTMENT [ORAZEN INC]	1	Current NDC, 2 package rows	20230219_f4e4854a-ee01-df72-e053-2995a90aa8ea.zip
71927-017	MEDI-FIRST (BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE) OINTMENT [ORAZEN INC]	1	Current NDC, 2 package rows	20230219_f4e4d0a4-b90c-99b0-e053-2995a90ab423.zip
71927-017	MEDI-FIRST (BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE) OINTMENT [ORAZEN INC]	1	Current NDC, 2 package rows	20230219_f4e42c5c-e080-4efb-e053-2a95a90af52e.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 4 of 22 · 424 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lynx LX0864 peachy-foam antiseptic handsoap	CHLOROXYLENOL	ABC Compounding Co., Inc.	dd8025cb-d160-83a4-e053-2a95a90a51ac	2026-05-11	Warnings	Exact identifier application number: M004
Satin Foam High Foaming Antiseptic Hand Wash	CHLOROXYLENOL	Certus Medical, Inc.	ea49da65-ae5e-bfde-e053-2a95a90adef2	2026-05-11	Warnings	Exact identifier application number: M004
Freshands Premium Foamy Antibacterial Handsoap 6876	CHLOROXYLENOL	Consolidated Chemicals, LLC	f17299a4-28d6-e65b-e053-2a95a90a05e7	2026-05-11	Warnings	Exact identifier application number: M004
Harris Teeter Triple Antibiotic and Pain Relief	NEOMYCIN SULFATE, POLYMYXIN B SULFATE, BACITRACIN ZINC, PRAMOXINE HCL	HARRIS TEETER LLC	4b0c0a3c-7145-97ca-e063-6394a90a1a96	2026-05-07	Warnings	Exact identifier application number: M004
Harris Teeter Triple Antibiotic	NEOMYCIN SULFATE, POLYMYXIN B SULFATE, BACITRACIN ZINC	HARRIS TEETER LLC	4e81590c-32d3-f8aa-e063-6294a90ab341	2026-05-06	Warnings	Exact identifier application number: M004
FIRSTAR TRIPLE ANTIBIOTIC	BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	Nantong Health & Beyond Hygienic Products Inc.	5b9434ad-83d7-4df3-bfef-3db152e6c6cc	2026-05-04	Warnings	Exact identifier application number: M004
oopsie First Aid	BACITRACIN ZINC NEOMYCIN SULFATE POLYMYXIN B SULFATE	4 Visions LLC	50b21f0a-1e87-51ae-e063-6294a90a8a3c	2026-04-30	Warnings	Exact identifier application number: M004
First Aid Kit, Lil Drug Store	5 ADHESIVE BANDAGES, 2 ANTIBIOTIC OINTMENTS	Lil' Drug Store Products, Inc.	503c6c0e-3e1a-71ed-e063-6394a90abfa2	2026-04-24	Warnings	Exact identifier application number: M004
Triple Antibiotic	BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE.	TRIFECTA PHARMACEUTICALS USA LLC	23a35ba8-ebc6-4252-bb88-ec237425056c	2026-04-15	Warnings	Exact identifier application number: M004
El Valle Gentian Violet	GENTIAN VIOLET 1%	Pharmadel LLC	fc75aa2b-0e6e-e2f7-e053-6294a90ac01f	2026-04-13	Warnings	Exact identifier application number: M004
Bacitracin Zinc	BACITRACIN ZINC	Sun Pharmaceutical Industries, Inc.	4afdeedf-9cdf-47d6-919f-ea907fda0290	2026-04-10	Warnings	Exact identifier application number: M004
Family Care Triple Antibiotic Original Formula 0.33oz	TRIPLE ANTIBIOTIC ORIGINAL FORMULA	United Exchange Corp	4f1ef127-a67e-ca60-e063-6394a90a3a3d	2026-04-10	Warnings	Exact identifier application number: M004
Triple Antibiotic	BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B, PRAMOXINE HYDROCHLORIDE	H E B	2a143950-13b4-457e-91a4-c61a88aad84b	2026-04-02	Warnings	Exact identifier application number: M004
Triple Antibiotic	BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE.	ProStat First Aid, LLC.	4e54f479-ad87-e86b-e063-6394a90aa6d2	2026-03-31	Warnings	Exact identifier application number: M004
El Valle Merthiolate	BENZALKONIUM CHLORIDE	Pharmadel LLC	fd7b28ca-9f71-0ff6-e053-6394a90a4822	2026-03-26	Warnings	Exact identifier application number: M004
sojo Triple Antibiotic	TRIPLE ANTIBIOTIC	Jiangxi Yudexi Pharmaceutical Co., LTD	4d8429bd-24b9-ad3c-e063-6294a90aeba0	2026-03-21	Warnings	Exact identifier application number: M004
Neosporin Plus Pain Relief Clubtray	BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE	Kenvue Brands LLC	f4545718-8643-a340-e053-2995a90a0079	2026-03-18	Warnings	Exact identifier application number: M004
Bacitracin	BACITRACIN	Preferred Pharmaceuticals Inc.	2f115e22-10f5-47fe-85df-f59e4387a373	2026-03-16	Warnings	Exact identifier application number: M004
Triple Antibiotic	BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE.	ProStat First Aid, LLC.	4cd49c65-e347-7589-e063-6394a90a53bd	2026-03-12	Warnings	Exact identifier application number: M004
Triple Antibiotic	BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE.	ProStat First Aid, LLC.	4cc6d822-f383-2ceb-e063-6294a90aecc7	2026-03-11	Warnings	Exact identifier application number: M004

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
89Y4M234ES	BACITRACIN ZINC	1405-89-6	BACITRACIN ZINC
057Y626693	NEOMYCIN SULFATE	1405-10-3	NEOMYCIN SULFATE
19371312D4	POLYMYXIN B SULFATE	1405-20-5	POLYMYXIN B SULFATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
204602	bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment	PSN	f4e42c5c-e080-4efb-e053-2a95a90af52e	2
204602	bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment	PSN	f4e4854a-ee01-df72-e053-2995a90aa8ea	2
204602	bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment	PSN	f4e4d0a4-b90c-99b0-e053-2995a90ab423	2
204602	bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment	SCD	f4e42c5c-e080-4efb-e053-2a95a90af52e	2
204602	bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment	SCD	f4e4854a-ee01-df72-e053-2995a90aa8ea	2
204602	bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment	SCD	f4e4d0a4-b90c-99b0-e053-2995a90ab423	2
204602	bacitracin 400 UNT / neomycin 3.5 MG (as neomycin sulfate 5 MG) / polymyxin B 5000 UNT per GM Topical Ointment	SY	f4e42c5c-e080-4efb-e053-2a95a90af52e	2
204602	bacitracin 400 UNT / neomycin 3.5 MG (as neomycin sulfate 5 MG) / polymyxin B 5000 UNT per GM Topical Ointment	SY	f4e4854a-ee01-df72-e053-2995a90aa8ea	2
204602	bacitracin 400 UNT / neomycin 3.5 MG (as neomycin sulfate 5 MG) / polymyxin B 5000 UNT per GM Topical Ointment	SY	f4e4d0a4-b90c-99b0-e053-2995a90ab423	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
71927-017-01	71927001701	0.5 g in 1 POUCH	0.5 g				Historical
71927-017-02	71927001702	25 POUCH in 1 BOX (71927-017-02) / .5 g in 1 POUCH (71927-017-01)	25 pouch	2025-08-29	No	No	Current
71927-017-03	71927001703	144 POUCH in 1 BOX (71927-017-03) / .5 g in 1 POUCH (71927-017-01)	144 pouch	2025-09-03	No	No	Current
71927-017-04	71927001704	25 POUCH in 1 BOX (71927-017-04) / .5 g in 1 POUCH (71927-017-01)	25 pouch	2025-09-03	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
71927-017-01, -02, MEDI-FIRST Triple Antibiotic Ointment	Orazen Inc \| Nantong Health & Beyond Hygienic Products Inc.	2026-09-04	HUMAN OTC DRUG LABEL	3
71927-017-01, -03, MEDI-FIRST Triple Antibiotic Ointment	Orazen Inc \| Nantong Health & Beyond Hygienic Products Inc.	2026-09-04	HUMAN OTC DRUG LABEL	3
71729-017-01, -04 MEDI-FIRST PLUS Triple Antibiotic Ointment	Orazen Inc \| Nantong Health & Beyond Hygienic Products Inc.	2026-09-04	HUMAN OTC DRUG LABEL	3